Related Experiment Videos
Adenosine receptors and second messenger signaling pathways in rat cardiac fibroblasts
Sara A Epperson1, Laurence L Brunton, Israel Ramirez-Sanchez
1Department of Medicine, University of California, La Jolla, CA, USA.
Abstract:
The ability of adenosine (ADO) to inhibit proliferation and protein synthesis (in particular, collagen synthesis) in cardiac fibroblasts (CF) may ameliorate adverse cardiac remodeling and fibrosis seen in heart failure patients. However, little is known about the signaling pathways that ADO may modulate in CF to alter cell phenotype. Accordingly, this study was designed to identify ADO receptors (AR) and the signaling pathways linked to them in primary cultures of adult rat CF. Quantitative RT-PCR data indicate that the mRNAs for all four known ARs (A(1)R, A(2a)R, A(2b)R, and A(3)R) are present in rat CF, with a greater prevalence of A(2) receptor subtypes. No coupling of AR to the G(q)-phospholipase C signaling pathway or to mobilization of calcium is measurable. Studies using subtype specific agents imply that the A(2a)R and A(2b)R couple to G(s)-adenylyl cyclase and A(1)R couple weakly to G(i)-adenylyl cyclase. 2-Chloroadenosine, 5'-N-ethylcarboxamidoadensoine, and other agents that elevate cellular cAMP stimulate extracellular signal-regulated kinase 1/2 activity in a pertussis toxin-insensitive manner. We conclude that a combination of cAMP-dependent signals generated via A(2a) and A(2b) receptors likely mediate ADO signaling in adult rat CF.
Insights
Adenosine (ADO) may help heart failure by inhibiting cardiac fibroblast proliferation. This study identified adenosine receptors (ARs) and found that A(2a) and A(2b) receptors mediate ADO signaling via cAMP, impacting cell behavior.
Area of Science:
- Cardiovascular Biology
- Cellular Signaling
- Pharmacology
Background:
- Adenosine (ADO) inhibits cardiac fibroblast (CF) proliferation and collagen synthesis, potentially mitigating adverse cardiac remodeling in heart failure.
- The specific signaling pathways modulated by ADO in CF to alter cell phenotype remain largely unknown.
Purpose of the Study:
- To identify adenosine receptors (ARs) and their associated signaling pathways in primary cultures of adult rat cardiac fibroblasts (CF).
- To elucidate the mechanisms by which ADO influences CF phenotype and function.
Main Methods:
- Quantitative RT-PCR was used to detect the expression of all four known AR subtypes (A(1)R, A(2a)R, A(2b)R, A(3)R) in rat CF.
- Subtype-specific agents and pertussis toxin were employed to investigate AR coupling to G proteins (G(q), G(s), G(i)) and downstream signaling pathways, including calcium mobilization and adenylyl cyclase activity.
- Extracellular signal-regulated kinase 1/2 (ERK1/2) activity was measured in response to agents that elevate cyclic adenosine monophosphate (cAMP).
Main Results:
- All four AR subtypes (A(1)R, A(2a)R, A(2b)R, A(3)R) were detected in rat CF, with A(2) receptor subtypes being more prevalent.
- Adenosine receptors did not show coupling to the G(q)-phospholipase C pathway or calcium mobilization.
- A(2a)R and A(2b)R were found to couple to G(s)-adenylyl cyclase, while A(1)R showed weak coupling to G(i)-adenylyl cyclase. Elevated cAMP stimulated ERK1/2 activity in a pertussis toxin-insensitive manner.
Conclusions:
- Adenosine signaling in adult rat cardiac fibroblasts primarily involves A(2a) and A(2b) receptors.
- These receptors likely mediate their effects through cAMP-dependent signaling pathways.
- The identified signaling cascade, involving cAMP and ERK1/2 activation, is crucial for understanding ADO's role in regulating CF phenotype and potential therapeutic applications in heart failure.
Related Concept Videos
What are Second Messengers?
Insulin: The Receptor and Signaling Pathways
Amplifying Signals via Second Messengers
Intracellular Signaling Cascades
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway